Nanjing Qian Se Company Ltd.

Enoxaparin sodium is obtained by alkaline depolymerization of heparin benzyl ester derived from porcine intestinal mucosa. Its structure is characterized by 2-O-sulfo-4-enepyranosuronic acid group at the non-reducing end and a 2-N,6-O-disulfo-D-glucosamine at the reducing end of the chain. About 20% (ranging between 15% and 25%) of the enoxaparin structure contains a 1,6 anhydro derivative on the reducing end of the polysaccharide chain. It meets BP/EP requirements.

Ulinastatin is derived from human urine. Physical Appearance :White lyophilized powder.

SPECIFICATION: API

STANDARD: BP/EP